Marimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigen

Marimastat is a specific inhibitor of matrix metalloproteinases that has been shown to be effective in cancer models. A pilot, escalating-dose study of oral marimastat was performed in patients with recurrent colorectal cancer, in whom evaluation of serological response was made by measurement of ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Primrose, J N, Bleiberg, H, Daniel, F, Belle, S Van, Mansi, J L, Seymour, M, Johnson, P W, Neoptolemos, J P, Baillet, M, Barker, K, Berrington, A, Brown, P D, Millar, A W, Lynch, K P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362442/
https://www.ncbi.nlm.nih.gov/pubmed/10027321
http://dx.doi.org/10.1038/sj.bjc.6690079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362442/
https://www.ncbi.nlm.nih.gov/pubmed/10027321
http://dx.doi.org/10.1038/sj.bjc.6690079

Ejemplares similares